| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |